Investing
1535 Articles
Income investors watching the calendar have a narrow window this week. Three of the market’s most widely held high-yield names…
The S&P 500 keeps climbing, up nearly 9% year to date, and yet a handful of large-cap dividend payers are…
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality…
Healthcare has become Wall Street’s bargain bin in 2026, and value hunters are starting to pay attention. Drug pricing reform,…
Pre-Market Stock Futures: Futures are trading mixed as we get ready to start the first full week of trading for…
Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a…
Volatility can lower the cost of entry into businesses that throw off real cash, even as investors recognize that a…
I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I am not…
Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction). The stock trades at $24.37, and…
At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000 a year before…
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending…
Everyone is still arguing about Novo Nordisk (NYSE:NVO | NVO Price Prediction), the Danish obesity juggernaut whose GLP-1 franchise turned…
Eli Lilly (NYSE: LLY | LLY Price Prediction) and Pfizer (NYSE: PFE) just delivered Q1 2026 results that read like…
Passive income is the closest thing investors have to financial gravity. It pulls in money whether you are at your…
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again. Shares are up 9% today, trading near $57 in the…
Our top personal finance-related articles today. Your wallet will thank you later.